Scherlinger, M. et al. Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014. Autoimmun. Rev. 19, 102531 (2020).
Broen, J. C. A. & van Laar, J. M. Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology. Nat. Rev. Rheumatol. 16, 167–178 (2020).
Manzi, S. M. et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am. J. Epidemiol. 145, 408–415 (1997).
Conrad, N. et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet 400, 733–743 (2022). This large population-based study reports that multiple IMIDs are associated with increased risk of a wide range of cardiovascular diseases.
Gremmel, T., Frelinger, A. & Michelson, A. Platelet physiology. Semin. Thromb. Hemost. 42, 191–204 (2016).
Luo, D. et al. Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica. J. Immunol. 187, 1866–1876 (2011).
Gaertner, F. et al. Migrating platelets are mechano-scavengers that collect and bundle bacteria. Cell 171, 1368–1382.e23 (2017). This study shows that platelets actively patrol blood vessels to bind and bundle circulating bacteria, and promote neutrophil activation in infection.
Maouia, A., Rebetz, J., Kapur, R. & Semple, J. W. The immune nature of platelets revisited. Transfus. Med. Rev. 34, 209–220 (2020).
Marcoux, G., Laroche, A., Espinoza Romero, J. & Boilard, E. Role of platelets and megakaryocytes in adaptive immunity. Platelets 32, 340–351 (2021).
Bai, M. et al. Mean platelet volume could reflect disease activity of adult patients with systemic lupus erythematosus. Clin. Lab. 62, 1317–1322 (2016).
Khodashahi, M., Saadati, N., Rezaieyazdi, Z., Sahebari, M. & Saremi, Z. Evaluation of mean platelet volume in patients with rheumatoid arthritis and its relation with severity of disease. Rheumatol. Res. 4, 121–126 (2019).
Masoumi, M. et al. Correlation of clinical signs and symptoms of Behçet’s disease with mean platelet volume (MPV) and red cell distribution width (RDW). Orphanet J. Rare Dis. 15, 297 (2020).
Stenberg, P. E., Shuman, M. A., Levine, S. P. & Bainton, D. F. Redistribution of alpha-granules and their contents in thrombin- stimulated platelets. J. Cell Biol. 98, 748–760 (1984).
Duffau, P. et al. Platelet CD154 potentiates interferon- secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci. Transl. Med. 2, 47ra63 (2010). This study shows that platelets interact with pDCs in SLE and promote their production of type I interferon through the CD40L–CD40 axis.
Scherlinger, M. et al. Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis. Sci. Transl. Med. 13, eabi4994 (2021). This study shows that platelets from patients with SLE interact with Tregcells through the P-selectin–PSGL1 axis, which results in FOXP3 downregulation and Tregcell dysfunction.
Puhm, F., Boilard, E. & Machlus, K. R. Platelet extracellular vesicles: beyond the blood. Arterioscler. Thromb. Vasc. Biol. 41, 87–96 (2021).
Tessandier, N. et al. Platelets disseminate extracellular vesicles in lymph in rheumatoid arthritis. Arterioscler. Thromb. Vasc. Biol. 40, 929–942 (2020).
Melki, I. et al. FcγRIIA expression aggravates nephritis and increases platelet activation in systemic lupus erythematosus in mice. Blood https://doi.org/10.1182/blood.2020004974 (2020).
Melki, I. et al. Platelets release mitochondrial antigens in systemic lupus erythematosus. Sci. Transl. Med. 13, eaav5928 (2021). This study reports that activated platelets release mitochondria, either free or embedded in extracellular vesicles, that activate the immune system and participate in immune dysregulation in SLE.
Ohyama, K. et al. Proteomic profiling of antigens in circulating immune complexes associated with each of seven autoimmune diseases. Clin. Biochem. 48, 181–185 (2015).
Hubbard, J. J. et al. FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunity. J. Exp. Med. 217, e20200359 (2020).
Qian, K. et al. Functional expression of IgA receptor FcαRI on human platelets. J. Leukoc. Biol. 84, 1492–1500 (2008).
Joseph, M. et al. Expression and functions of the high-affinity IgE receptor on human platelets and megakaryocyte precursors. Eur. J. Immunol. 27, 2212–2218 (1997).
Chalayer, E. et al. Fc receptors gone wrong: a comprehensive review of their roles in autoimmune and inflammatory diseases. Autoimmun. Rev. 21, 103016 (2022).
Love, P. E. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance. Ann. Intern. Med. 112, 682 (1990).
Assous, N. et al. Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury. Clin. Exp. Rheumatol. 23, 199–204 (2005).
Fauchais, A. L. et al. Antiphospholipid antibodies in primary Sjögren’s syndrome: prevalence and clinical significance in a series of 74 patients. Lupus 13, 245–248 (2004).
Zhang, W. et al. Anti-β2 glycoprotein I antibodies in complex with β2 glycoprotein I induce platelet activation via two receptors: apolipoprotein E receptor 2′ and glycoprotein I bα. Front. Med. 10, 76–84 (2016).
Müller-Calleja, N. et al. Lipid presentation by the protein C receptor links coagulation with autoimmunity. Science 371, eabc0956 (2021).
Kim, K.-J., Baek, I.-W., Yoon, C.-H., Kim, W.-U. & Cho, C.-S. Elevated levels of soluble CD40 ligand are associated with antiphospholipid antibodies in patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 35, 823–830 (2017).
Patsouras, M. D. et al. Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome. J. Autoimmun. 65, 30–37 (2015).
Provan, D. & Semple, J. W. Recent advances in the mechanisms and treatment of immune thrombocytopenia. eBioMedicine 76, 103820 (2022).
Al-Samkari, H. et al. A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia. Blood Adv. 4, 9–18 (2019).
Kuwana, M., Kaburaki, J., Okazaki, Y., Miyazaki, H. & Ikeda, Y. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus. Rheumatology 45, 851–854 (2006).
Czirják, L. et al. Anti-platelet antibodies against gpIIb/IIIa in systemic sclerosis. Clin. Exp. Rheumatol. 12, 527–529 (1994).
Hally, K., Fauteux-Daniel, S., Hamzeh-Cognasse, H., Larsen, P. & Cognasse, F. Revisiting platelets and Toll-like receptors (TLRs): at the interface of vascular immunity and thrombosis. Int. J. Mol. Sci. 21, 6150 (2020).
Aslam, R. et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107, 637–641 (2006).
Andonegui, G. et al. Platelets express functional Toll-like receptor-4. Blood 106, 2417–2423 (2005).
Ward, J. R. et al. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb. Haemost. 94, 831–838 (2005).
Vogel, S. et al. Platelet-derived HMGB1 is a critical mediator of thrombosis. J. Clin. Invest. 125, 4638–4654 (2015).
Koupenova, M. et al. Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. Blood 124, 791–802 (2014).
Brown, G. J. et al. TLR7 gain-of-function genetic variation causes human lupus. Nature 605, 349–356 (2022). This study shows that constitutive activation of TLR7 causes early and severe SLE in mice and humans.
Becker, Y. et al. Autoantibodies in systemic lupus erythematosus target mitochondrial RNA. Front. Immunol. 10, 1026 (2019).
Becker, Y. L., Julien, A.-S., Godbout, A., Boilard, É. & Fortin, P. R. Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome. Lupus 29, 1623–1629 (2020).
Thon, J. N. et al. The functional role of TLR9 in human platelets. Blood 118, 366 (2011).
Boudreau, L. H. et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 124, 2173–2183 (2014).
Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375, 296–301 (2022).
留言 (0)